AceRNA specializes in the development of patient-centric novel genetic therapies based on evidence-based drug-discovery process.
AceRNA was founded in 2018 by Shin Teruo.
1282 health care and life sciences companies are in the directory, 519 of them in the same 11-50 employee range and 156 based in Asia-Pacific (APAC).
“我々は活性型マイクロRNAの探索を通じて再生医療と希少疾患等の創薬シードの発見に貢献します。 私たちは、細胞・遺伝子治療の開発をしているバイオベンチャーです。_aceRNA Technologies” acernatec.com
AceRNA has a 11-50 person team and operates in biopharma, listed under Asia-Pacific (APAC), and has been around since 2018. It has raised $282 million over 3 rounds and its founder is Shin Teruo.
11-50 employees · alxoncology.com
11-50 employees · a-biodesign.com
11-50 employees · adm-labs.com
51-100 employees · 4basebio.com
501-1,000 employees · apcerls.com
1-10 employees · 101therapeutics.com
11-50 employees · advancells.com
11-50 employees · aardvarktherapeutics.com
11-50 employees · 3tbiosciences.com
251-500 employees · actgenomics.com
Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.